108 related articles for article (PubMed ID: 27364860)
1. Rebound Thymic Hyperplasia after Chemotherapy in Children with Lymphoma.
Chen CH; Hsiao CC; Chen YC; Ko SF; Huang SH; Huang SC; Hsieh KS; Sheen JM
Pediatr Neonatol; 2017 Apr; 58(2):151-157. PubMed ID: 27364860
[TBL] [Abstract][Full Text] [Related]
2. [Rebound (reactive) thymic hyperplasia after chemotherapy in children with lymphoma].
Fouda A; Kandil S; Hamid G; Boujettif K; Mahfouz M; Abdelaziz M
An Pediatr (Engl Ed); 2019 Sep; 91(3):189-198. PubMed ID: 30713069
[TBL] [Abstract][Full Text] [Related]
3. Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphoma.
Franke FC; Damek A; Steglich J; Kurch L; Hasenclever D; Georgi TW; Wohlgemuth WA; Mauz-Körholz C; Körholz D; Kluge R; Landman-Parker J; Wallace WH; Fosså A; Vordermark D; Karlen J; Fernández-Teijeiro A; Cepelova M; Klekawka T; Attarbaschi A; Ceppi F; Hraskova A; Uyttebroeck A; Beishuizen A; Dieckmann K; Leblanc T; Moellers M; Buerke B; Stoevesandt D
Pediatr Blood Cancer; 2023 Aug; 70(8):e30421. PubMed ID: 37243889
[TBL] [Abstract][Full Text] [Related]
4. Reactive thymic hyperplasia following chemotherapy for children with lymphoma: computed tomography may be able to provide valuable information to avoid over-treatment.
Tian L; Cai PQ; Cui CY; Mo YX; Gong X; Fan W
Eur J Cardiothorac Surg; 2015 May; 47(5):883-9. PubMed ID: 25079775
[TBL] [Abstract][Full Text] [Related]
5. [Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].
Zhen ZJ; Sun XF; Xia Y; Wang ZH; Ling JY
Ai Zheng; 2006 Apr; 25(4):471-5. PubMed ID: 16613683
[TBL] [Abstract][Full Text] [Related]
6. Positive gallium-67 and thallium-201 scans in thymic rebound after chemotherapy for lymphoma.
Akaki S; Shinya T; Sato S; Kuroda M; Kanazawa S
Ann Nucl Med; 2006 Feb; 20(2):161-3. PubMed ID: 16615427
[TBL] [Abstract][Full Text] [Related]
7. Predictors for reactive thymic hyperplasia and its prognostic value in children and adolescents with lymphoma.
Hu YY; Tian L; Zhang X; Xiao ZZ; Zhang WD; Lin XP; Zhang YR; Long W; Fan W
Eur J Radiol; 2018 Dec; 109():108-113. PubMed ID: 30527291
[TBL] [Abstract][Full Text] [Related]
8. The role of PET-CT in the differential diagnosis of thymic mass after treatment of patients with lymphoma.
Ustaalioglu BB; Seker M; Bilici A; Canpolat N; Yıldirim E; Kefeli U; Ustaalioglu R; Yilmaz BE; Salepci T; Ozdemir N; Gumus M
Med Oncol; 2011 Mar; 28(1):258-64. PubMed ID: 20155405
[TBL] [Abstract][Full Text] [Related]
9. Post-Chemotherapy Rebound Thymic Hyperplasia Mimicking Relapse in Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Case Report.
Lazaro-Garcia A; Lacalle-Gonzalez C; Santonja C; Rodríguez-Pinilla SM; Cornejo JI; Morillo D
Oncol Res Treat; 2021; 44(4):196-200. PubMed ID: 33730738
[TBL] [Abstract][Full Text] [Related]
10. Cervical lymph node hyperplasia on [(18)F]-fluorodeoxyglucose positron emission tomography/computed tomography scan after treatment of children and adolescents with malignant lymphoma.
Hu YY; Zhang X; Long W; Lin XP; Zhang YR; Li YH; Xiao ZZ; Zheng RL; Liang PY; Fan W
Eur J Radiol; 2015 Jul; 84(7):1378-82. PubMed ID: 25882963
[TBL] [Abstract][Full Text] [Related]
11. High frequency of benign mediastinal uptake of gallium-67 after completion of chemotherapy in children with high-grade non-Hodgkin's lymphoma.
Peylan-Ramu N; Haddy TB; Jones E; Horvath K; Adde MA; Magrath IT
J Clin Oncol; 1989 Dec; 7(12):1800-6. PubMed ID: 2585021
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?
Spaepen K; Stroobants S; Dupont P; Van Steenweghen S; Thomas J; Vandenberghe P; Vanuytsel L; Bormans G; Balzarini J; De Wolf-Peeters C; Mortelmans L; Verhoef G
J Clin Oncol; 2001 Jan; 19(2):414-9. PubMed ID: 11208833
[TBL] [Abstract][Full Text] [Related]
13. Thallium-201 scintigraphy for assessment of a gallium-67-avid mediastinal mass following therapy for Hodgkin's disease.
Harris EW; Rakow JI; Weiner M; Agress H
J Nucl Med; 1993 Aug; 34(8):1326-30. PubMed ID: 8326393
[TBL] [Abstract][Full Text] [Related]
14. Thymic rebound hyperplasia post-chemotherapy mistaken as disease progression in a patient with lymphoma involving mediastinum: a case report and reflection.
Qiu L; Zhao Y; Yang Y; Huang H; Cai Z; He J
BMC Surg; 2021 Jan; 21(1):38. PubMed ID: 33446156
[TBL] [Abstract][Full Text] [Related]
15. Chemical-shift MRI of rebound thymic hyperplasia with unusual appearance and intense (18)F-FDG uptake in adulthood: report of two cases.
Priola AM; Priola SM
Clin Imaging; 2014; 38(5):739-42. PubMed ID: 24667047
[TBL] [Abstract][Full Text] [Related]
16. High rate of unnecessary thymectomy and its cause. Can computed tomography distinguish thymoma, lymphoma, thymic hyperplasia, and thymic cysts?
Ackman JB; Verzosa S; Kovach AE; Louissaint A; Lanuti M; Wright CD; Shepard JO; Halpern EF
Eur J Radiol; 2015 Mar; 84(3):524-533. PubMed ID: 25575742
[TBL] [Abstract][Full Text] [Related]
17. [Filling the thymic space after treatment of Hodgkin's disease: rebound or relapse].
Margery J; de Revel T; Magois E; Bonardel G; Leduc I; Saint-Blancard P; Bonnichon A; Vaylet F; Jancovici R; Nedellec G
Rev Pneumol Clin; 2007 Feb; 63(1):45-7. PubMed ID: 17457284
[TBL] [Abstract][Full Text] [Related]
18. Gallium 67 uptake in thymic rebound.
Hurst R; Sabio H; Teates CD
South Med J; 1988 Sep; 81(9):1167-9. PubMed ID: 3420448
[TBL] [Abstract][Full Text] [Related]
19. Increased metabolic activity in the thymus gland studied with 18F-FDG PET: age dependency and frequency after chemotherapy.
Brink I; Reinhardt MJ; Hoegerle S; Altehoefer C; Moser E; Nitzsche EU
J Nucl Med; 2001 Apr; 42(4):591-5. PubMed ID: 11337547
[TBL] [Abstract][Full Text] [Related]
20. Rebound thymic hyperplasia after pneumonectomy and chemotherapy for primary synovial sarcoma.
Ford ME; Stevens R; Rosado-de-Christenson ML; Hall NC; Suster S
J Thorac Imaging; 2008 Aug; 23(3):178-81. PubMed ID: 18728544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
